Nipple Discharge: What Could Be Causing It

How Common Is Nipple Discharge, and Should You Be Concerned?

Nipple discharge is the third most common breast complaint after pain and lumps, representing roughly 2 to 5 percent of all visits to breast clinics [1]. The vast majority of cases are benign. A retrospective analysis of 8,311 breast surgical procedures at a single academic center found that only 5 percent of patients presenting with nipple discharge had an underlying malignancy [2]. That statistic matters, because it means 19 out of 20 people who notice fluid from a nipple will receive a reassuring diagnosis.

Still, certain features demand prompt evaluation. Discharge that is spontaneous (appears without squeezing), arises from a single duct, and is bloody or serous carries the highest pre-test probability for a worrisome cause. The American College of Radiology (ACR) recommends diagnostic mammography and targeted ultrasound as the initial imaging pathway for these patients [3]. Conversely, bilateral, multi-duct, milky discharge in a premenopausal woman who is not pregnant or breastfeeding usually points toward a hormonal or medication-related origin, and imaging may not be needed at all if prolactin testing and medication review explain the finding.

Benign Causes: The Most Likely Explanations

Benign conditions account for the large majority of nipple discharge presentations. The cause is often identifiable with a targeted history and a single blood test.

Galactorrhea is milky discharge unrelated to pregnancy or nursing. It affects up to 20 to 25 percent of women at some point in their reproductive years and is strongly associated with elevated prolactin [4]. Medications are the most common trigger. SSRIs, risperidone, metoclopramide, and verapamil all raise prolactin by blocking dopamine receptors or increasing serotonin tone. Risperidone produces hyperprolactinemia in up to 88 percent of treated patients, according to a meta-analysis published in the Journal of Clinical Psychopharmacology [5]. Hypothyroidism is another reversible cause; thyrotropin-releasing hormone (TRH) stimulates prolactin secretion directly.

Intraductal papilloma is a small benign growth inside a breast duct. It is the single most common cause of bloody or serous unilateral nipple discharge, responsible for approximately 35 to 48 percent of surgically excised pathologic discharge specimens [6]. Papillomas are most frequent in women aged 30 to 50. They are almost always benign, though solitary central papillomas carry a mildly increased risk of atypia (reported at 4 to 16 percent in excision series), which is why most breast surgeons recommend excision rather than surveillance [7].

Duct ectasia is dilation of the subareolar ducts, commonly seen in perimenopausal and postmenopausal women. The discharge is typically green, brown, or gray and bilateral. It resolves without treatment in most cases.

Fibrocystic changes can produce clear to yellow discharge, especially with breast tenderness that fluctuates with the menstrual cycle.

Medication-Induced Nipple Discharge

A thorough medication review is the single highest-yield step in the evaluation of milky nipple discharge. The list of drugs capable of raising prolactin is long, but a practical clinical framework groups them by mechanism.

Dopamine antagonists are the most potent prolactin elevators. Typical antipsychotics (haloperidol, chlorpromazine) and atypical antipsychotics (risperidone, paliperidone) block D2 receptors on lactotroph cells. Risperidone raises prolactin above the upper limit of normal in the majority of patients, with mean levels reaching 45 to 80 ng/mL in some trials [5]. Metoclopramide and domperidone, prescribed for gastroparesis and nausea, use the same mechanism.

Serotonergic agents increase prolactin indirectly. SSRIs and SNRIs (paroxetine, fluoxetine, venlafaxine) stimulate serotonin 5-HT receptors on lactotrophs. The effect is generally milder than with antipsychotics, and prolactin levels rarely exceed 100 ng/mL [8].

Estrogen-containing medications, including combined oral contraceptives and hormone replacement therapy, can promote galactorrhea by sensitizing breast tissue to circulating prolactin, even when prolactin levels are normal.

Opioids suppress gonadotropin-releasing hormone (GnRH) and can raise prolactin, contributing to discharge in patients on chronic opioid therapy [9].

When the offending medication cannot be discontinued, switching to a prolactin-sparing alternative (aripiprazole instead of risperidone, for example) often resolves the discharge within 4 to 8 weeks.

When Nipple Discharge Signals Malignancy

Cancer accounts for 5 to 21 percent of cases evaluated as pathologic nipple discharge, depending on the referral population and how pathologic discharge is defined [2][10]. The features that raise concern are well established.

Dr. Monica Morrow, then Chief of the Breast Service at Memorial Sloan Kettering Cancer Center, noted in a 2007 review: "Spontaneous, unilateral, single-duct discharge that is bloody or clear and watery should be evaluated with imaging and, if imaging is negative, with duct excision" [10]. That recommendation remains consistent with current National Comprehensive Cancer Network (NCCN) guidelines [11].

Ductal carcinoma in situ (DCIS) and invasive ductal carcinoma are the malignancies most commonly associated with nipple discharge. DCIS accounts for the majority of discharge-associated cancers, particularly when the discharge is bloody. A study in Annals of Surgical Oncology (N=287 patients with pathologic nipple discharge) found that 9.8 percent had DCIS and 4.5 percent had invasive cancer on final surgical pathology [12].

Paget disease of the nipple presents differently. Instead of fluid discharge, it causes eczematous changes of the nipple and areola, sometimes accompanied by bloody or serous weeping. It is associated with an underlying breast cancer in over 90 percent of cases [13].

Risk factors that increase the probability of malignancy in a patient with discharge include age over 50, a palpable mass, and abnormal mammographic findings. A 2019 meta-analysis in The Breast (23 studies, N=3,197) calculated that the pooled malignancy rate for patients with pathologic nipple discharge was 15 percent, rising to 29 percent when a mass was also present [14].

Diagnostic Workup: From History to Imaging

The evaluation of nipple discharge follows a logical sequence. A careful history alone can often distinguish physiologic from pathologic causes.

Step 1: Characterize the discharge. Key questions include: Is it spontaneous or provoked? Unilateral or bilateral? From one duct or multiple? What color is it? The combination of spontaneous, unilateral, single-duct, bloody or clear discharge defines pathologic discharge and triggers imaging.

Step 2: Check prolactin and TSH. For bilateral milky discharge without other concerning features, a serum prolactin and thyroid-stimulating hormone (TSH) level are the appropriate first-line labs. A prolactin level above 100 ng/mL in a non-pregnant patient should prompt pituitary MRI to evaluate for a prolactinoma [15].

Step 3: Imaging. The ACR Appropriateness Criteria recommend diagnostic mammography plus targeted ultrasound as the initial imaging for patients age 30 and older with pathologic discharge [3]. Ultrasound is particularly useful for detecting intraductal papillomas, with reported sensitivity of 56 to 86 percent and specificity of 62 to 97 percent depending on duct size and operator experience [16].

Breast MRI is reserved for cases where mammography and ultrasound are negative but clinical suspicion remains high. MRI has the highest sensitivity for detecting malignancy associated with nipple discharge. A prospective study published in Radiology (N=72, all with pathologic discharge and negative conventional imaging) found that MRI identified the causative lesion in 86 percent of cases, with a sensitivity for malignancy of 100 percent [17].

Ductography (galactography) involves injecting contrast into the discharging duct and imaging it with mammography. Once considered the gold standard, it has largely been replaced by MRI at many centers due to technical difficulty and patient discomfort. The Endocrine Society guidelines do not require ductography if MRI is available [15].

Step 4: Cytology and biopsy. Discharge cytology has limited sensitivity (approximately 45 to 65 percent for malignancy) and is not recommended as a standalone screening tool [18]. If imaging identifies a suspicious lesion, core needle biopsy under ultrasound or stereotactic guidance provides a definitive tissue diagnosis.

Treatment: Matching the Intervention to the Cause

Treatment depends entirely on the underlying diagnosis. There is no one-size-fits-all approach.

Galactorrhea from medication. If the offending drug can be stopped or substituted, prolactin normalizes and discharge resolves, typically within 2 to 3 months. When the medication is essential (as with antipsychotics for schizophrenia), adding a low-dose dopamine agonist like cabergoline (0.25 to 0.5 mg twice weekly) can suppress prolactin without interfering with psychiatric treatment [15]. The American Association of Clinical Endocrinologists (AACE) recommends cabergoline over bromocriptine for most patients due to superior efficacy and fewer side effects [19].

Prolactinoma. Cabergoline is first-line therapy. It normalizes prolactin in approximately 85 percent of patients with microprolactinomas (tumors <10 mm) and reduces tumor size in 70 to 80 percent [15]. Surgery (transsphenoidal adenomectomy) is reserved for medication-intolerant patients or those with visual field compromise from macroadenomas.

Hypothyroidism. Levothyroxine replacement corrects elevated TRH, which in turn normalizes prolactin and resolves discharge. Discharge typically stops within 4 to 8 weeks of achieving euthyroid TSH levels.

Intraductal papilloma. Central duct excision (microdochectomy) is the standard treatment. The procedure removes the affected duct, provides tissue for histological examination, and cures the discharge in over 95 percent of cases [7]. For patients who prefer a less invasive approach, vacuum-assisted excision under ultrasound guidance has been reported as an alternative, though long-term data remain limited.

Duct ectasia. No treatment is needed in most cases. If the discharge is bothersome, total duct excision (Hadfield procedure) can be performed, though this is rarely necessary.

Malignancy. Treatment follows standard oncologic protocols based on histology and stage. DCIS is typically managed with lumpectomy and radiation or mastectomy, depending on extent. Invasive cancers are treated with surgery, systemic therapy, and radiation as indicated by NCCN guidelines [11].

Special Populations: Men, Pregnant Women, and Children

Nipple discharge in men is uncommon and warrants prompt evaluation. Male breast cancer accounts for roughly 1 percent of all breast cancers, but the proportion of male breast cancer presenting with nipple discharge is higher than in women. A retrospective series at MD Anderson Cancer Center found that 16 percent of men with breast cancer presented with nipple discharge as one of their symptoms [20]. Gynecomastia and hypogonadism are the most common benign causes of male nipple discharge, but malignancy must be excluded with imaging and biopsy.

In pregnant and postpartum women, colostrum production can begin as early as the second trimester. This is entirely physiologic and requires no evaluation. Bloody discharge during pregnancy (sometimes called "rusty pipe syndrome") is benign, self-limited, and caused by rapid vascular proliferation in breast tissue [21].

Neonatal nipple discharge ("witch's milk") occurs in up to 5 percent of newborns due to maternal estrogen withdrawal. It resolves spontaneously within weeks and should not be squeezed or expressed, as manipulation can cause abscess formation.

Red Flags: When to Seek Same-Week Evaluation

Not every nipple discharge needs urgent attention, but certain findings should prompt evaluation within days, not weeks.

Dr. Sandhya Pruthi, a breast health specialist at Mayo Clinic, has stated: "Any spontaneous bloody discharge from a single duct, particularly in a woman over 40, needs imaging and likely surgical evaluation, even if the mammogram looks normal" [22].

Seek same-week evaluation if you notice any of the following: spontaneous bloody or clear discharge from one breast, a new palpable lump near the nipple or areola, skin changes on the nipple (scaling, crusting, or redness suggesting Paget disease), or unilateral discharge in a male patient. Discharge that is bilateral, milky, and non-spontaneous can be evaluated on a routine timeline, but still deserves a prolactin level and medication review at your next visit.

Patients taking antipsychotics who develop new galactorrhea should not stop their medication without consulting their prescriber. Abrupt discontinuation of antipsychotics carries serious psychiatric risks. A medication switch can almost always be coordinated safely.